Variable | N=1698, n (%) | Missing, n |
---|---|---|
Gender | 0 | |
Female | 852 (50.2) | |
Male | 846 (49.8) | |
Education (years) | 20 | |
<10 | 544 (32) | |
10–12 | 700 (42) | |
>12 | 434 (26) | |
Living situation | 7 | |
Alone | 349 (21) | |
With spouse/partner | 737 (43) | |
With spouse/partner and children | 376 (22) | |
With others (children or adults) | 210 (13) | |
In an institution | 19 (1) | |
Country | 0 | |
Australia, 1 site | 35 (2) | |
Belgium, 1 site | 95 (6) | |
Bulgaria, 1 site | 28 (2) | |
Canada, 2 sites | 94 (6) | |
Denmark, 2 sites | 100 (6) | |
Georgia, 1 site | 19 (1) | |
Italy, 7 sites | 605 (35) | |
Norway, 4 sites | 235 (14) | |
Portugal, 1 site | 58 (3) | |
Spain, 4 sites | 233 (14) | |
Switzerland, 2 sites | 68 (4) | |
UK, 4 sites | 128 (7) | |
Treatment setting | 38 | |
Inpatients | 348 (21) | |
Outpatients | 1017 (61) | |
Home care | 295 (18) | |
Comorbidity (numbers) | 5 | |
0 | 679 (40) | |
1 | 638 (39) | |
2 | 283 (16) | |
3 or more | 93 (5) | |
Primary cancer diagnosis* | 4 | |
Digestive organs | 520 (31) | |
Respiratory organs† | 343 (20) | |
Breast cancer | 284 (17) | |
Male genital organs | 126 (7) | |
Gynaecological | 99 (6) | |
Urinary | 75 (4) | |
Head | 58 (4) | |
Leukaemia or lymphoma | 44 (3) | |
Malignant connective/soft-tissue tumours | 40 (2) | |
Skin cancer/malignant melanoma | 36 (2) | |
CNS tumours | 24 (1) | |
Secondary/ill-defined malignant tumours | 24 (1) | |
Malignant endocrine tumours | 11 (1) | |
Other‡ | 10 (1) | |
Disease status | 8 | |
Metastatic/disseminated | 1414 (83) | |
Local/locally advanced | 276 (17) | |
Survival, days from inclusion | 663§ | |
<30 | 151 (15) | |
30–89 | 299 (29) | |
90–149 | 184 (18) | |
150–180 | 67 (6) | |
>180 | 334 (32) | |
Treatment with chemotherapy at inclusion | 3 | |
Yes | 707 (42) | |
No | 998 (58) | |
Treatment with chemotherapy by the survival group (days) | ||
<30 | 23 (15) | |
30–89 | 80 (27) | |
90–149 | 85 (46) | |
150–180 | 26 (39) | |
>180 | 162 (49) | |
Treatment with opioids at inclusion | 22 | |
Yes | 991 (59) | |
No | 685 (41) |
*Based on ICD-10 diagnoses from patient records.
†Including eight patients with laryngeal cancer.
‡Including malignant bone tumours (n=8), multiple primary cancers (n=2).
§Incl. 25 patients reported dead, but with no date registered.